Former Google China President Kai-Fu Lee believes the rise of AI “will come in waves,” he told FOX Business. Lee said healthcare is one of the industries that will benefit the most from AI. 

The FDA is cracking down on the supplement industry, after Commissioner Scott Gottlieb, MD, asked the makers of 12 different supplements to cease claiming their products cure various diseases, including Alzheimer’s disease, diabetes and cancer, among others. Additionally, Gottlieb announced a new plan for policy advancements in an effort to modernize dietary supplement regulation and oversight.

Living in food deserts—residential areas with low net income and poor access to healthy food—was independently linked to adverse outcomes in patients with coronary artery disease in a study of nearly 5,000 subjects, researchers reported Feb. 11 in the Journal of the American Heart Association.

While many men with low-risk prostate cancer have been known to undergo immediate surgery or radiation treatment, a new study in JAMA found that more men are choosing active surveillance. 

Researchers have detected gadolinium in gliomas, adjacent normal brain tissue and necrosis tissue in patients who underwent MRI scans, according to new findings published in Neuroradiology.

Administrators at the NHS Highland health board in Scotland have been accused of “blacklisting” after refusing to hire three veteran radiologists amid a severe staff shortage, according to a report in The Herald.

California-based Pr3vent Inc., an AI healthcare company, closed its Series A financing, spearheaded by venture capital firm InFocus Capital Partners. 

Healthcare spending per person rose to an all-time high in 2017 for those covered by employer-sponsored insurance, according to the Health Care Cost Institute (HCCI). Average healthcare spending per individual rose 4.2 percent to $5,641, including medical and pharmacy claims.